ArticleJournal of biomedical science2024

EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment.

Debasmita Dutta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.